FATE THERAPEUTICS INC (FATE)

US31189P1021 - Common Stock

4.1  +0.01 (+0.24%)

After market: 4.1 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
63.53M96.30M55.85M31.43M10.68M
Operating Expenses
254.04M404.69M272.84M159.52M111.41M
Research and Development
172.60M320.45M215.52M125.62M87.77M
Selling, General, and Administrative Expenses
81.45M84.23M57.32M33.90M23.64M
Operating Income
-190.51M-308.39M-216.99M-128.09M-100.73M
Interest Income/Expense
19.70M26.15M4.84M-45.30M2.58M
Other Income/Expense
9.88M520.00KN/AN/AN/A
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-160.93M-281.72M-212.15M-173.39M-98.15M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-160.93M-281.72M-212.15M-173.39M-98.15M
EBITDA
-172.23M-294.63M-211.14M-125.00M-98.54M
 
Per Share Data
EPS Diluted Total Ops
-1.64-2.91-2.24-2.10-1.44
Non GAAP EPS
-1.64-2.91-2.23-2.08-1.43
 
Statistics
Profit Margin
-253.30%-292.54%-379.86%-551.67%-919.01%
Operating Profit Margin
-299.86%-320.24%-388.52%-407.54%-943.16%

All data in USD

Charts